Validation of the clinical treatment score post 5 years (CTS5) in women with hormone receptor positive, HER2-negative, node-negative disease from the TAILORx study
View/ Open
Volume
80
DOI
10.1158/1538-7445.SABCS19-GS4-03
Issue
ISSN
0008-5472
Metadata
Show full item recordAuthors
Sestak, I; Crager, M; Cuzick, J; Dowsett, M; Shak, S; Tang, G; Gray, R; Sparano, JCollections
- Centre for Cancer Prevention [1181]